DT-101

N/A

Report date: 2026/04/25 20:00:23
NME

Base Information

Drug NameDT-101
Drug Alias NameDT-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate receptor ionotropic AMPA positive allosteric modulator
TargetsGlutamate receptor ionotropic AMPA
Therapy Area/IndicationsDepressive Disorder, Major
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaUnited States +[5] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesDraig Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesDraig Therapeutics LtdDraig Therapeutics
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, Major
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A